CTGF、TGF-β1与非ST段抬高型急性冠脉综合征患者冠脉病变程度相关性的研究进展
Research Progress on the Correlation between CTGF, TGF-β1 and the Degree of Coronary Lesions in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome
摘要: CTGF (结缔组织生长因子)和TGF-β1 (转化生长因子-β1)是两种具有广泛生物学活性的细胞信号分子，参与细胞增殖、迁移、分化及细胞外基质的合成与沉积，尤其在纤维化过程中起重要作用。TGF-β1是CTGF表达的最强诱导剂之一，两者在多种病理过程中表现出协同作用。目前，已有大量研究表明两者在心肌纤维化中起到关键作用。同时多项研究表明，血清CTGF和TGF-β1水平与冠状动脉粥样硬化的发展进程存在密切关系，可为临床提供更敏感的疾病评估指标。其与冠状动脉病变复杂及严重程度的相关性，一直作为近年来学者的研究热点。非ST段抬高急性冠状动脉(冠脉)综合征(non-ST segment elevation acute coronary syndrome, NSTE-ACS)的核心病理机制为冠状动脉粥样病变基础上继发血栓形成和/或痉挛。临床上NSTE-ACS患者在冠状动脉狭窄基础上，往往同时伴有弥漫性多支血管病变。本文旨在分析NSTE-ACS患者中CTGF和TGF-β1水平与SYNTAX评分之间的相关性并进行比较。
Abstract: CTGF (connective tissue growth factor) and TGF-β1 (transforming growth factor-β1) are two cell signaling molecules with extensive biological activities, participating in cell proliferation, migration, differentiation, and the synthesis and deposition of extracellular matrix, especially playing a significant role in the process of fibrosis. TGF-β1 is one of the strongest inducers of CTGF expression, and the two exhibit a synergistic effect in various pathological processes. Currently, numerous studies have demonstrated that they play a crucial role in myocardial fibrosis. Meanwhile, multiple studies have shown that the levels of serum CTGF and TGF-β1 are closely related to the development process of coronary atherosclerosis, providing more sensitive disease assessment indicators for clinical practice. The correlation between them and the complexity and severity of coronary artery lesions has been a research hotspot in recent years. The core pathological mechanism of non-ST segment elevation acute coronary syndrome (NSTE-ACS) lies in the secondary thrombosis and/or spasm on the basis of coronary atherosclerotic lesions. Clinically, patients with NSTE-ACS often have diffuse multi-vessel lesions in addition to coronary artery stenosis. This article aims to analyze and compare the correlation between the levels of CTGF and TGF-β1 and the SYNTAX score in patients with NSTE-ACS.
文章引用：孙嘉玉, 孙宓颖. CTGF、TGF-β1与非ST段抬高型急性冠脉综合征患者冠脉病变程度相关性的研究进展[J]. 临床医学进展, 2025, 15(5): 1827-1833. https://doi.org/10.12677/acm.2025.1551563

参考文献

[1] 俞坤武, 曾秋棠. 《非ST段抬高型急性冠脉综合征诊断和治疗指南(2024)》解读[J]. 临床心血管病杂志, 2024, 40(9): 697-700.
[2] 张新超, 于学忠, 陈凤英, 等. 急性冠脉综合征急诊快速诊治指南(2019) [J]. 中国急救医学, 2019, 39(4): 301-308.
[3] Denktas, A.E. (2021) Ischemia-Guided Approach versus Early Invasive Approach for NSTE-ACS: How Early Is Early? Current Cardiology Reports, 23, Article No. 34. [Google Scholar] [CrossRef] [PubMed]
[4] Bhatt, D.L., Lopes, R.D. and Harrington, R.A. (2022) Diagnosis and Treatment of Acute Coronary Syndromes: A Review. JAMA, 327, 662-675. [Google Scholar] [CrossRef] [PubMed]
[5] Kotanidis, C.P., Mills, G.B., Bendz, B., Berg, E.S., Hildick-Smith, D., Hirlekar, G., et al. (2024) Invasive vs. Conservative Management of Older Patients with Non-ST-Elevation Acute Coronary Syndrome: Individual Patient Data Meta-analysis. European Heart Journal, 45, 2052-2062. [Google Scholar] [CrossRef] [PubMed]
[6] Amsterdam, E.A. and Wenger, N.K. (2015) The 2014 American College of Cardiology ACC/American Heart Association Guideline for the Management of Patients with Non-ST‐Elevation Acute Coronary Syndromes: Ten Contemporary Recommendations to Aid Clinicians in Optimizing Patient Outcomes. Clinical Cardiology, 38, 121-123. [Google Scholar] [CrossRef] [PubMed]
[7] 张维, 辉红蕾, 李金龙, 许钟艺, 尹冶, 王玉明. 不同性别和年龄的非心肌损伤人群血清高敏心肌肌钙蛋白T水平差异[J]. 中国循环杂志, 2020, 35(1): 31-36.
[8] Granger, C.B., Goldberg, R.J., Dabbous, O., Pieper, K.S., Eagle, K.A., Cannon, C.P., et al. (2003) Predictors of Hospital Mortality in the Global Registry of Acute Coronary Events. Archives of Internal Medicine, 163, 2345-2353. [Google Scholar] [CrossRef] [PubMed]
[9] 黄振华, 廖瑾莉, 肖孝勇, 叶子, 蒋鹏, 陈伟栋, 等. GRACE评分对急性胸痛患者30 d心血管不良事件的预测价值[J]. 中山大学学报(医学科学版), 2018, 39(1): 82-86.
[10] 张玲玲. 急诊科首次肌钙蛋白I联合GRACE评分对急性心肌梗死的预测价值分析[J]. 中国现代药物应用, 2025, 19(4): 74-77.
[11] Farooq, V., Head, S.J., Kappetein, A.P. and Serruys, P.W. (2013) Widening Clinical Applications of the SYNTAX Score. Heart, 100, 276-287. [Google Scholar] [CrossRef] [PubMed]
[12] Serruys, P.W., Morice, M., Kappetein, A.P., Colombo, A., Holmes, D.R., Mack, M.J., et al. (2009) Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease. New England Journal of Medicine, 360, 961-972. [Google Scholar] [CrossRef] [PubMed]
[13] Virmani, R., Kolodgie, F.D., Burke, A.P., Farb, A. and Schwartz, S.M. (2000) Lessons from Sudden Coronary Death: A Comprehensive Morphological Classification Scheme for Atherosclerotic Lesions. Arteriosclerosis, Thrombosis, and Vascular Biology, 20, 1262-1275. [Google Scholar] [CrossRef] [PubMed]
[14] Libby, P. (2002) Inflammation in Atherosclerosis. Nature, 420, 868-874. [Google Scholar] [CrossRef] [PubMed]
[15] Savarese, G., Edner, M., Dahlström, U., Perrone-Filardi, P., Hage, C., Cosentino, F., et al. (2015) Comparative Associations between Angiotensin Converting Enzyme Inhibitors, Angiotensin Receptor Blockers and Their Combination, and Outcomes in Patients with Heart Failure and Reduced Ejection Fraction. International Journal of Cardiology, 199, 415-423. [Google Scholar] [CrossRef] [PubMed]
[16] Jugdutt, B.I. and Amy, R.W.M. (1986) Healing after Myocardial Infarction in the Dog: Changes in Infarct Hydroxyproline and Topography. Journal of the American College of Cardiology, 7, 91-102. [Google Scholar] [CrossRef] [PubMed]
[17] Fishbein, M.C., Meerbaum, S., Rit, J., Lando, U., Kanmatsuse, K., Mercier, J.C., et al. (1981) Early Phase Acute Myocardial Infarct Size Quantification: Validation of the Triphenyl Tetrazolium Chloride Tissue Enzyme Staining Technique. American Heart Journal, 101, 593-600. [Google Scholar] [CrossRef] [PubMed]
[18] Sun, Y. and Weber, K.T. (2000) Infarct Scar: A Dynamic Tissue. Cardiovascular Research, 46, 250-256. [Google Scholar] [CrossRef] [PubMed]
[19] 谢亚芹, 刘宏伟, 李秀芬, 等. 转化生长因子-β和结缔组织生长因子在慢性心力衰竭大鼠心肌纤维化中的动态表达[J]. 解剖学杂志, 2011, 34(4): 446-449.
[20] Jahan, N. and Hannila, S.S. (2015) Transforming Growth Factor β-Induced Expression of Chondroitin Sulfate Proteoglycans Is Mediated through Non-Smad Signaling Pathways. Experimental Neurology, 263, 372-384. [Google Scholar] [CrossRef] [PubMed]
[21] Almendral, J.M., Sommer, D., Macdonald-Bravo, H., Burckhardt, J., Perera, J. and Bravo, R. (1988) Complexity of the Early Genetic Response to Growth Factors in Mouse Fibroblasts. Molecular and Cellular Biology, 8, 2140-2148. [Google Scholar] [CrossRef] 
[22] Bradham, D.M., Igarashi, A., Potter, R.L. and Grotendorst, G.R. (1991) Connective Tissue Growth Factor: A Cysteine-Rich Mitogen Secreted by Human Vascular Endothelial Cells Is Related to the SRC-Induced Immediate Early Gene Product CEF-10. The Journal of Cell Biology, 114, 1285-1294. [Google Scholar] [CrossRef] [PubMed]
[23] Leask, A., Parapuram, S.K., Shi‐wen, X. and Abraham, D.J. (2009) Connective Tissue Growth Factor (CTGF, CCN2) Gene Regulation: A Potent Clinical Bio‐Marker of Fibroproliferative Disease? Journal of Cell Communication and Signaling, 3, 89-94. [Google Scholar] [CrossRef] [PubMed]
[24] Lipson, K.E., Wong, C., Teng, Y. and Spong, S. (2012) CTGF Is a Central Mediator of Tissue Remodeling and Fibrosis and Its Inhibition Can Reverse the Process of Fibrosis. Fibrogenesis & Tissue Repair, 5, S24. [Google Scholar] [CrossRef] [PubMed]
[25] Pan, L., Yamauchi, K., Uzuki, M., Nakanishi, T., Takigawa, M., Inoue, H., et al. (2001) Type II Alveolar Epithelial Cells and Interstitial Fibroblasts Express Connective Tissue Growth Factor in IPF. European Respiratory Journal, 17, 1220-1227. [Google Scholar] [CrossRef] [PubMed]
[26] Yokoi, H., Mukoyama, M., Sugawara, A., Mori, K., Nagae, T., Makino, H., et al. (2002) Role of Connective Tissue Growth Factor in Fibronectin Expression and Tubulointerstitial Fibrosis. American Journal of Physiology-Renal Physiology, 282, F933-F942. [Google Scholar] [CrossRef] [PubMed]
[27] Hayashi, N., Kakimuma, T., Soma, Y., et al. (2002) Connective Tissue Growth Factor Is Directly Related to Liver Fibrosis. Hepatogas-Troenterology, 49, 133-135.
[28] Dean, R.G., Balding, L.C., Candido, R., Burns, W.C., Cao, Z., Twigg, S.M., et al. (2005) Connective Tissue Growth Factor and Cardiac Fibrosis after Myocardial Infarction. Journal of Histochemistry & Cytochemistry, 53, 1245-1256. [Google Scholar] [CrossRef] [PubMed]
[29] Oemar, B.S. and Lüscher, T.F. (1997) Connective Tissue Growth Factor. Friend or Foe? Arteriosclerosis, Thrombosis, and Vascular Biology, 17, 1483-1489. [Google Scholar] [CrossRef] [PubMed]
[30] Ross, R. (1999) Mechanisms of Disease: Atherosclerosis—An Inflammatory Disease. The New England Journal of Medicine, 41, 376.
[31] Ohnishi, H., Oka, T., Kusachi, S., Nakanishi, T., Takeda, K., Nakahama, M., et al. (1998) Increased Expression of Connective Tissue Growth Factor in the Infarct Zone of Experimentally Induced Myocardial Infarction in Rats. Journal of Molecular and Cellular Cardiology, 30, 2411-2422. [Google Scholar] [CrossRef] [PubMed]
[32] Grotendorst, G.R. and Duncan, M.R. (2005) Individual Domains of Connective Tissue Growth Factor Regulate Fibroblast Proliferation and Myofibroblast Differentiation. The FASEB Journal, 19, 729-738. [Google Scholar] [CrossRef] [PubMed]
[33] Watts, K.L. and Spiteri, M.A. (2004) Connective Tissue Growth Factor Expression and Induction by Transforming Growth Factor-β Is Abrogated by Simvastatin via a Rho Signaling Mechanism. American Journal of Physiology-Lung Cellular and Molecular Physiology, 287, L1323-L1332. [Google Scholar] [CrossRef] [PubMed]
[34] 敖翔. CTGF在心血管疾病中的研究进展[J]. 国外医学(生理、病理科学与临床分册), 2003(5): 466-468.
[35] 李勇, 李莉, 祁春梅, 等. 急性ST段抬高型心肌梗死患者血清结缔组织生长因子表达的研究[J]. 中国循环杂志, 2015, 30(6): 540-542.
[36] 张春阳. 结缔组织生长因子在冠状动脉狭窄形成中的作用及临床诊断价值研究[D]: [硕士学位论文]. 贵阳: 贵州医科大学, 2016.

为你推荐